Integra LifeSciences (IART) PT Lowered to $22 at Citizens on Specialty Surgical Business Headwinds

October 22, 2026 5:13 AM

Citizens analyst David Turkaly lowered the price target on Integra LifeSciences (NASDAQ: IART) to $22.00 (from $25.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found